Studioverse
The computed 12-month bankruptcy probability of Studioverse is 0.7% (low). The 2024 annual accounts show equity of €62k and a net result of €10k. Equity is growing by ~17.6% per year across the filed fiscal years. Its solvency ranks better than 80% of 1480 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €62k |
| Net result | €10k |
| Better than sector | 80% |
| Active | 4 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 75.0% | 50.1% | |
| Net result | €10k | €12k | |
| Equity | €62k | €32k | |
| Gross operating margin | €20k | €28k | |
| Staff costs | €0 | €17k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €18k |
| Net profit | €10k |
| Cash flow | €15k |
| Staff costs | €0 |
| Income taxes | €3k |
| Dividends | - |
| Total assets | €83k |
| Equity | €62k |
| Debt | €21k |
| of which ≤ 1y | €21k |
| of which > 1y | - |
| Working capital | €16k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 1.79 |
| Quick ratio | 1.79 |
| Working capital ratio | 19.7% |
| Solvency | 75.0% |
| Debt / equity | 0.33 |
| Long-term debt ratio | - |
| Interest coverage | 12.78 |
| Gross margin | - |
| Net margin | - |
| ROA | 11.6% |
| ROE | 15.5% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €83k |
| Fixed assets | 21/28 | €46k |
| Tangible fixed assets | 22/27 | €19k |
| Financial fixed assets | 28 | €27k |
| Current assets | 29/58 | €37k |
| Amounts receivable within one year | 40/41 | €7k |
| Cash & bank | 54/58 | €27k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €83k |
| Equity | 10/15 | €62k |
| Contributions / capital | 10/11 | €3k |
| Accumulated profits (losses) | 14 | €60k |
| Amounts payable | 17/49 | €21k |
| Amounts payable within one year | 42/48 | €21k |
| Trade debts payable within one year | 44 | €4k |
| Income statement | ||
| Gross operating margin | 9900 | €20k |
| Operating result | 9901 | €13k |
| Financial income | 75 | €985 |
| Financial charges | 65 | €1k |
| Result before taxes | 9903 | €12k |
| Income taxes | 67/77 | €3k |
| Net result for the period | 9904 | €10k |
| Result to be appropriated | 9905 | €10k |
| NACE primary | 74201 |
| Legal form | Private limited company(610) |
| Incorporation | 21-12-2021 |
| Status | Active |
| Postal code | 2240 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11054A0253/00G004 | Flanders | 127 m² | 1 · 187 m² | 9.1 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
06-02-2026 Registered office moved from Zoersel to Zandhoven
- Handelslei 142, 2980 Zoersel → Langestraat 213, 2240 Zandhoven
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Zandhoven",
"region": null,
"street": "Langestraat",
"country": "BE",
"postcode": "2240",
"box_number": null,
"street_number": "213"
},
"old_address": {
"city": "Zoersel",
"region": null,
"street": "Handelslei",
"country": "BE",
"postcode": "2980",
"box_number": null,
"street_number": "142"
},
"effective_date": "2026-01-01",
"evidence_quote": "De bestuurder beslist om de zetel van de vennootschap te verplaatsen van 2980 Zoersel, Handelslei 142 naar 2240 Zandhoven, Langestraat 213, en dit vanaf 01/01/2026."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0778.912.275",
"name_full": "STUDIOVERSE",
"legal_form": "BV"
}
}23-12-2021 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "2980 Zoersel, Handelslei 142",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1995-08-18",
"name": "Van den Brande-De Groof, Elien",
"niss": null,
"address": "2240 Zandhoven, Het Ven 15"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 2500,
"holder_person_name": "Van den Brande-De Groof, Elien",
"is_subscriber_only": false,
"n_shares_subscribed": 1,
"amount_subscribed_eur": 2500,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 2500,
"subject_company": {
"kbo": "0778.912.275",
"name_full": "Studioverse",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2021-12-21",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Studioverse |